| Bioactivity | BTA-EG4 is a catalase-amyloid interaction inhibitor, which can significantly enhance the neurotoxicity of amyloid peptides in catalase-overexpressing neuronal cells, and can be used in the study of neurodegenerative diseases[1]. |
| Name | BTA-EG4 |
| CAS | 921193-28-4 |
| Formula | C22H28N2O4S |
| Molar Mass | 416.53 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Amrutha Chilumuri, et al. Benzothiazole Aniline Tetra(ethylene glycol) and 3-Amino-1,2,4-triazole Inhibit Neuroprotection against Amyloid Peptides by Catalase Overexpression in Vitro.Amrutha Chilumuri, Mark Odell, and Nathaniel G. N. Milton.ACS Chemical Neuroscience 2013 4 (11), 1501-1512. |
BTA-EG4
CAS: 921193-28-4 F: C22H28N2O4S W: 416.53
BTA-EG4 is a catalase-amyloid interaction inhibitor, which can significantly enhance the neurotoxicity of amyloid peptid
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.